TILRAY $TLRYWell movement. Volume is super. just hit the resistance and rsi is oversold. after some correction next target; $9.56 , $11.76
TLRY
$TLRY Springs Higher, Trendline Resistance AboveTLRY is not a company we have been fans of, generally speaking. The debt-servicing costs are astronomical, and the company seemed to hit the public markets as a kind of cardboard cut-out fashioned for the show ahead of some big catalysts. But the bounce from $2 appears to be somewhat more substantial.
Maybe $300 to $2 was enough of a pullback for now?
TLRYcould TLRY become a penny stock? This company stock has lost the last line of support around $22. and now is descending into the depth of hell with no sign of reversing.. But whenever it looks ready to turn Ima buy the fuck out this stock
TSLA/TLRY CompareOnly comparison is euphoria, no comparison on product or market but we'll see how this goes from here.
TILRAY INC (TLRY) DailyDates in the future with the highest probability for price direction reversals
TLRY LONG SET UP BUY TILRAY Option expire date in march-june
ENTRY 1 18.60
ENTRY 2 17.80
ENTRY 3 16.68
SL 8.00
TP.1 23
TP.2 35
TP.3 48
TP.4 68
TP.5 76
TP.6 96
TP.7 123
TP.8 154
TILRAY (TLRY) LONG SET UP, TREND REVERSAL TO $154BUY TILRAY
ENTRY 1 16.80
ENTRY 2 18.60
ENTRY 3 19.34
SL 8.00
TP.1 23
TP.2 35
TP.3 48
TP.4 68
TP.5 76
TP.6 96
TP.7 123
TP.8 154
Bullish Daily Chart on $MJDaily Chart is looking like a great long-term buy down here. Watching for a move over the daily 50sma and a continuation higher above $20.
It's been a rough ride down since March of 2019, We trended all the way back down to 2017 support on the North American Cannabis Sector shown here -> charts.stocktwits.com
I'm anticipating for this to hit $50 in the 5 years
GLTA and Reinvest those dividends back into MJ :)
$CGC Canopy EOY 2019, Inverted H&S in play? R:R 1:10$CGC Canopy EOY 2019, Inverted H&S in play? R:R 1:10
Picture explains the most, R:R makes it lovely.
Not financial adice
LONG ACB AURORA CANNABISBuy low sell high. Showing signs of a bottom. 2018 4.00 support level looks to be tested which computes a 50% upside from current levels. Could experience an echo bubble type move like other equities have in the past. Pot stocks starting to get a little more attention recently.
$ACB 76.8 fib retracement done, -0.27 fib target.$ACB $CGC $TLRYBought a lot of ACB around $3 last week. Went crazy the week, but then retraced to fib 78.6
Cannabis 2.0 - chance to growFundamentals are now better.
Prices are better.
Regulations & Govs are more ready for it.
Early bottom assumtion. Confirmation + Adding on growth.
TLRY: Bottomed, Easy.Either this is going to zero or we bottomed; I would like to believe we bottomed. Take this or don't. I entered this yesterday with an entry of $20.99 (~7%+ already).
If you saw before, $TLRY jumped from $20-$300 (~1400% gains) in just about two months. Definitely one to watch.
Loving the TLRY Chart!Not all that excited about TLRY fundamentally yet, but love this chart! Large Bullish Divergence at major support, I think this thing is close to popping big-time.
Tilray - About to make a huge step!Tilray shares are about to make a bounce back up. The shares have taken a 70% haircut in 2019, we think it's time to get back in to this stock.
"Tilray sold $15.8 million worth of recreational weed. International medical cannabis sales increased to $5.7 million from $949,000 a year ago. Tilray Chief Executive Brendan Kennedy said in an interview with MarketWatch that he attributes the international cannabis sales to investments the company made in 2017 and 2018 that are now beginning to bear fruit."
www.marketwatch.com
finance.yahoo.com
TLRY - DAILY CHARTHi, today we are going to talk about Tilray and its current landscape.
A dichotomy surges today on the Tilray Inc after the company reported its earnings yesterday with a worse than expected Earnings Per Share (EPS) -66.67% lower than forecasted and a better than expected Revenue, surpassing markets expectations in +3.05%. The increase in revenue was attributed to the stellar growth of pot sale reported by the company, with the help of European markets the company pulled off an increase of 5 times on its sales compared to the last year. A good signal for the company that gains traction on its pathway to becoming profitable.
Thank you for reading and leave your comments if you like.
To have access to our exclusive contents, join the Traders Heaven today! Link Below.
Disclaimer: All content of Golden Dragon has only educational and informational purposes, and never should be used or take it as financial advice.
THE WEEK AHEAD: CRON, TLRY, CGC EARNINGS; EWZ; VIXHIGH RANK/IMPLIED EARNINGS:
CRON (32/82) (Tuesday Before Open)
TLRY (50/97) (Tuesday After Close)
CSCO (44/27) (Tuesday After Close)
WMT (48/23) (Thursday Before Open)
NVDA (24/43) (Thursday After Close)
AMAT (17/34) (Thursday After Close)
CGC (95/87) (Thursday Before Open)
JC (30/43) (Friday Before Open)
Notes: Looks like it's the "Week of Weed" with CRON, TLRY, CGC announcing and all in states of high implied/high rank ... . If you're hesitant to go into single name here, MJ (47/51) has decent rank/implied metrics, although it's less liquid than I would like.
EXCHANGE-TRADED FUNDS:
TLT (56/12)
EWZ (47/28)
SLV (44/22)
GDXJ (37/31)
GLD (34/11)
EEM (33/16)
First Expiries In Which At-the-Money Short Straddle Pays >10% of Stock Price:
TLT: January of '21
EWZ: March: 5.64 verus 43.02 (13.11%)
SLV: April: 1.72 versus 15.70 (11.0%)
GDXJ: January: 3.99 versus 36.33 (11.0%)
GLD: January of '21
EEM: June: 4.97 versus 43.68 (11.4%)
Notes: Pictured here is an EWZ delta-neutral short strangle camped out at the 20 delta in the first expiry in which the at-the-money short straddle pays greater than 10% of the value of the underlying. Paying 1.61, it has break evens of 35.39/50.61 with delta/theta metrics of -.36/1.49; .40 at 25% maximum; .80 at 50%.
BROAD MARKET:
Broad market premium selling simply isn't paying here in short duration (an understatement).
FUTURES:
/6B (72/9)
/NG (74/60)
/SI (44/21)
/GC (34/12)
/ZS (32/20)
Notes: Natty is frisking up, which should be no surprise. Having put on a bullish assumption seasonality play in UNG way back in August at lows, I'm just waiting for things to top out in January or February before doing something in the other direction.
VIX/VIX DERIVATIVES:
Term structure trades* in VIX remain viable for the December, January, and February expiries with the correspondent futures contracts trading at 16.05, 17.33, and 18.07 respectively.
On the other end of the stick, continue to consider a VXX Super Bull or similar setup to potentially catch a modest volatility expansion running into the end of the year without sticking your entire pickle in the grinder, particularly if VIX continues to trundle along at 2019 lows: the December 20th 16P/-18P/18C/-20C pays a small credit (.17), has a 17.83 break even versus spot of 18.64, and max profit/max loss metrics of 2.17/1.87, with max being realized on a finish above 20, which does not exactly require a massive pop from here.
* -- Generally short call verticals with break even near where the correspondent /VX futures contract is trading (e.g., the December 20th 15/18, paying .90, with a 15.90 break even versus the December /VX contract trading at 16.05; the January 22nd 16/19, 1.00, with a 17.00 break even versus 17.33; February 19th 17/20, with an 18.00 break even versus 18.07).
TILRAY - Major Bullish SignalsWeekly RSI bullish divergence plus break-out above the downtrend line. Still in the accumulative zone and previous week closed TD5 Downtrend and this week on TD1 Uptrend.
Moving Average Convergence Divergence (MACD) indicator also showing bullish divergence and crossed to bull mode. Overall this looks like a great entry and if it goes lower even better to scale in longterm.
It also appears to have completed 3 down waves in a falling wedge or downtrend channel.
Please like and comment if you agree or have a different view!
Good to go, happy trading.
-TheTrex
